Moderna settles Covid vaccine patent suit for up to $2.25 billion

This story has been up to date.

Moderna has agreed to pay Roivant as much as $2.25 billion to settle claims that the mRNA vaccine developer infringed on Roivant’s patents in its Covid-19 shot.

Roivant will obtain $950 million after which one other $1.3 billion if Moderna’s makes an attempt to have components of its legal responsibility offloaded to the federal authorities fail upon enchantment. If the complete quantity is paid, will probably be among the many largest patent settlements in historical past.